Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NSCLC Patients With Brain Metastasis”

188 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 188 results

Testing effectiveness (Phase 2)Study completedNCT02312622
What this trial is testing

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer (NSCLC)Recurrent Non-small Cell Lung Cancer (NSCLC)Extensive-stage Small Cell Lung Cancer (SCLC)+3 more
Joel Neal 27
Large-scale testing (Phase 3)UnknownNCT00955695
What this trial is testing

Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Center, Korea 242
Large-scale testing (Phase 3)Ended earlyNCT02162537
What this trial is testing

Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung CancerAdenocarcinoma of Lung Metastatic to Brain+1 more
Centre Hospitalier Intercommunal Creteil 95
Testing effectiveness (Phase 2)Study completedNCT03526900
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis

Who this might be right for
Non-small Cell Lung Cancer Stage IV
Spanish Lung Cancer Group 40
Testing effectiveness (Phase 2)Study completedNCT04345146
What this trial is testing

Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Study completedNCT02085070
What this trial is testing

MK-3475 in Melanoma and NSCLC Patients With Brain Metastases

Who this might be right for
MelanomaNon-Small Cell Lung CancerBrain Metastases
Yale University 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06683703
What this trial is testing

Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer Patients with Brain Metastases
Beijing Biostar Pharmaceuticals Co., Ltd. 118
Testing effectiveness (Phase 2)Study completedNCT00871923
What this trial is testing

Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerBrain Cancer
M.D. Anderson Cancer Center 44
Testing effectiveness (Phase 2)Study completedNCT05465343
What this trial is testing

Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE)

Who this might be right for
FurmonertinibEGFR-mutationNSCLC+1 more
Peking Union Medical College 24
Early research (Phase 1)Study completedNCT03463525
What this trial is testing

Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 4
Testing effectiveness (Phase 2)Study completedNCT00219297
What this trial is testing

Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer

Who this might be right for
Brain MetastasisNon-small Cell Lung Cancer
Novartis Pharmaceuticals 50
Large-scale testing (Phase 3)Ended earlyNCT04588246
What this trial is testing

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more
NRG Oncology 19
Large-scale testing (Phase 3)Study completedNCT01951482
What this trial is testing

Pemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung Cancer

Who this might be right for
Non Squamous Non-small Cell Lung CancerBrain MetastasesBevacizumab
Sun Yat-sen University 160
Testing effectiveness (Phase 2)UnknownNCT05812534
What this trial is testing

Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Second Affiliated Hospital of Nanchang University 36
Early research (Phase 1)Study completedNCT00884598
What this trial is testing

Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer

Who this might be right for
Brain and Central Nervous System TumorsLung Cancer
Universitätsmedizin Mannheim 19
Post-approval studies (Phase 4)UnknownNCT01926171
What this trial is testing

Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

Who this might be right for
Non-small-cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT00372775
What this trial is testing

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Who this might be right for
Non-Small Cell Lung Cancer
Pfizer 66
Large-scale testing (Phase 3)Study completedNCT04768075
What this trial is testing

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Guangdong Association of Clinical Trials 60
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)UnknownNCT01130766
What this trial is testing

Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Samsung Medical Center 176
Next Page